Pharm'image
Entity

  • Pharm'image

    Created in 2008
  • BETA

    To investigate (B)
    Some signals may appear as inconsistent with a regular activity

  • Social networks

    309

  • Activities

    biotech deeptech healthtech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    64 Rue Sully, 21000 Dijon, France

    Dijon

    France

  • Employees

    Scale: 2-10

    Estimated: 1

  • SIREN

    503269615

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    3 years, 2 months ago
Description
  • Value proposition

    #Pharmaco-imaging, #nuclear medicine, #PET/MRI, #Radiochemistry, #Preclinical models

    Created in 2008 in Dijon, Pharm’image is a regional center of excellence in Pharmaco-imaging. Unique in France, it brings together hospitals, biotechnology, and pharmaceutical companies, to offer state-of-the-art of functional and molecular imaging technologies (MRI, PET, SPECT, CT), ranging from small-animal scale for preclinical experimentation to clinical exploitation

    Its aim is to deploy cutting-edge medical imaging technologies to evaluate biomarkers that can be used to track treatment efficacy and select the active and most promising drug candidates.

    imaging, preclinical evaluation, pharmacology, molecular imaging, nuclear medicine, radiochemistry, bioconjugation, translational research, in vivo pharmaco-imaging, First in man clinical trial, Cyclotron, optical imaging, MRI, SPECT, and PET

  • Original language

    #Pharmaco-imaging, #nuclear medicine, #PET/MRI, #Radiochemistry, #Preclinical models

    Created in 2008 in Dijon, Pharm’image is a regional center of excellence in Pharmaco-imaging. Unique in France, it brings together hospitals, biotechnology, and pharmaceutical companies, to offer state-of-the-art of functional and molecular imaging technologies (MRI, PET, SPECT, CT), ranging from small-animal scale for preclinical experimentation to clinical exploitation

    Its aim is to deploy cutting-edge medical imaging technologies to evaluate biomarkers that can be used to track treatment efficacy and select the active and most promising drug candidates.

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics